fluconazole has been researched along with Bacterial Pneumonia in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To demonstrate whether fluconazole reduces multiple organ failure and mortality in early septic shock (<24 hrs)." | 5.10 | Fluconazole improves survival in septic shock: a randomized double-blind prospective study. ( Al Omar, NF; Jacobs, S; Price Evans, DA; Tariq, M, 2003) |
| "Bacterial pneumonia is a common cause of death worldwide." | 1.46 | Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia. ( Du, L; Jin, Y; Li, M; Liu, B; Zhang, T; Zhu, L, 2017) |
| "A cryptococcus neoformans septicemia with meningoencephalitis was diagnosed." | 1.30 | Cryptococcosis, epileptic seizures and encephalopathy in a HIV-infected patient. ( Elzi, M; Reusser, P; Tolnay, M, 1997) |
| "Treatment with fluconazole was effective in 2 months on the cryptococcosis." | 1.29 | [Cutaneous and lymphatic cryptococcosis after transient lymphopenia in an immunocompetent patient]. ( Aubin, F; Barale, T; Gil, H; Humbert, P; Reboux, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M | 1 |
| Zhu, L | 1 |
| Zhang, T | 1 |
| Liu, B | 1 |
| Du, L | 1 |
| Jin, Y | 1 |
| Bardwell, J | 1 |
| August, J | 1 |
| Farran, S | 1 |
| Florita, C | 1 |
| Donovan, F | 1 |
| Zangeneh, TT | 1 |
| Wysham, NG | 1 |
| Sullivan, DR | 1 |
| Allada, G | 1 |
| Jacobs, S | 1 |
| Price Evans, DA | 1 |
| Tariq, M | 1 |
| Al Omar, NF | 1 |
| Gil, H | 1 |
| Aubin, F | 1 |
| Reboux, G | 1 |
| Barale, T | 1 |
| Humbert, P | 1 |
| Vassallo, J | 1 |
| Galizia, AC | 1 |
| Cuschieri, P | 1 |
| Tolnay, M | 1 |
| Elzi, M | 1 |
| Reusser, P | 1 |
| Lin, A | 1 |
| Stout, JE | 1 |
| Rihs, JD | 1 |
| Vickers, RM | 1 |
| Yu, VL | 1 |
1 trial available for fluconazole and Bacterial Pneumonia
| Article | Year |
|---|---|
Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Topics: Adult; Aged; Antifungal Agents; Cross Infection; Double-Blind Method; Female; Fluconazole; Hospital | 2003 |
7 other studies available for fluconazole and Bacterial Pneumonia
| Article | Year |
|---|---|
Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antifungal Agents | 2017 |
Infection of Aortic Endograft Caused by Coccidioidomycosis.
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aortic Aneurysm, Abdominal; Aortitis | 2020 |
An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor.
Topics: Aged; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Enzyme Inhibitors; Fluconazole; Hu | 2013 |
[Cutaneous and lymphatic cryptococcosis after transient lymphopenia in an immunocompetent patient].
Topics: Aged; Aged, 80 and over; Cryptococcosis; Female; Fluconazole; Groin; Humans; Immunocompetence; Leg D | 1995 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination | 1996 |
Cryptococcosis, epileptic seizures and encephalopathy in a HIV-infected patient.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcus neo | 1997 |
Improved Legionella selective media by the addition of fluconazole: results of in vitro testing and clinical evaluation.
Topics: Anisomycin; Antifungal Agents; Bacteriological Techniques; Candida albicans; Community-Acquired Infe | 1999 |